Incidence of mortality and viral load suppression by clinical characteristics among participants in HIV care facilities in Bauchi State, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Cumulative treatment outcomes prevalence rates for patients in ART treatment from year 2020 to 2022 for study participant in Bauchi State. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival function analysis for LTFU according to Viral Load status and BMI status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Demographic characteristics of study participants from two ART facilities in Bauchi state, based on data retrieved covering a three-year period from 2020 to 2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Annual incidence rate per 100 person-years trend for ART treatment outcomes. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Additional questions on vaccination. by Sara Saleh (6733619)

Subjects:

Socio-demographic characteristics of the population. by Sara Saleh (6733619)

Subjects:

Knowledge, attitude and practice scores in the general population and according to regions. by Sara Saleh (6733619)

Subjects:

The raw data file. by Sara Saleh (6733619)

Subjects:

Side effects of vaccination that affected participants’ children. by Sara Saleh (6733619)

Subjects:

Status (A) and duration (B) of breast feeding among participants. by Sara Saleh (6733619)

Subjects:

Bivariate analysis of sociodemographic and other factors associated with the knowledge scores. by Sara Saleh (6733619)

Subjects:

Bivariate analysis of sociodemographic and other factors associated with the attitude scores. by Sara Saleh (6733619)

Subjects:

Multivariate analysis of sociodemographic and other factors associated with the KAP scores. by Sara Saleh (6733619)

Subjects:

Participants’ perceived ways to boost children’s immune system other than vaccination. by Sara Saleh (6733619)

Subjects:

Bivariate analysis of sociodemographic and other factors associated with the practice scores. by Sara Saleh (6733619)

Subjects:

PBM significantly reduces hyperphosphorylation of tau with no effect on total tau expression. by Kevin J. Johnson (2647639)

Frequency distribution of SOLEC at baseline and follow-ups in WAD grade 2 and WAD grade 3. by Anneli Peolsson (7867601)

Subjects:

The CONSORT flow diagram. by Anneli Peolsson (7867601)

Subjects:

Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness. by Anneli Peolsson (7867601)

Subjects: